1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antibacterial Treatment 1.2.3 Antiviral Treatment 1.2.4 Antifungal Treatment 1.3 Market by Application 1.3.1 Global Nosocomial Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Ventilator Associated Pneumonia 1.3.3 Urinary Tract Infection 1.3.4 Blood Stream Infection 1.3.5 Surgical Site Infection 1.3.6 Gastrointestinal Infection 1.3.7 MRSA 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nosocomial Infection Treatment Market Perspective (2016-2027) 2.2 Nosocomial Infection Treatment Growth Trends by Regions 2.2.1 Nosocomial Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Nosocomial Infection Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Nosocomial Infection Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Nosocomial Infection Treatment Industry Dynamic 2.3.1 Nosocomial Infection Treatment Market Trends 2.3.2 Nosocomial Infection Treatment Market Drivers 2.3.3 Nosocomial Infection Treatment Market Challenges 2.3.4 Nosocomial Infection Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nosocomial Infection Treatment Players by Revenue 3.1.1 Global Top Nosocomial Infection Treatment Players by Revenue (2016-2021) 3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Nosocomial Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Nosocomial Infection Treatment Revenue 3.4 Global Nosocomial Infection Treatment Market Concentration Ratio 3.4.1 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nosocomial Infection Treatment Revenue in 2020 3.5 Nosocomial Infection Treatment Key Players Head office and Area Served 3.6 Key Players Nosocomial Infection Treatment Product Solution and Service 3.7 Date of Enter into Nosocomial Infection Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nosocomial Infection Treatment Breakdown Data by Type 4.1 Global Nosocomial Infection Treatment Historic Market Size by Type (2016-2021) 4.2 Global Nosocomial Infection Treatment Forecasted Market Size by Type (2022-2027) 5 Nosocomial Infection Treatment Breakdown Data by Application 5.1 Global Nosocomial Infection Treatment Historic Market Size by Application (2016-2021) 5.2 Global Nosocomial Infection Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Nosocomial Infection Treatment Market Size (2016-2027) 6.2 North America Nosocomial Infection Treatment Market Size by Type 6.2.1 North America Nosocomial Infection Treatment Market Size by Type (2016-2021) 6.2.2 North America Nosocomial Infection Treatment Market Size by Type (2022-2027) 6.2.3 North America Nosocomial Infection Treatment Market Size by Type (2016-2027) 6.3 North America Nosocomial Infection Treatment Market Size by Application 6.3.1 North America Nosocomial Infection Treatment Market Size by Application (2016-2021) 6.3.2 North America Nosocomial Infection Treatment Market Size by Application (2022-2027) 6.3.3 North America Nosocomial Infection Treatment Market Size by Application (2016-2027) 6.4 North America Nosocomial Infection Treatment Market Size by Country 6.4.1 North America Nosocomial Infection Treatment Market Size by Country (2016-2021) 6.4.2 North America Nosocomial Infection Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Nosocomial Infection Treatment Market Size (2016-2027) 7.2 Europe Nosocomial Infection Treatment Market Size by Type 7.2.1 Europe Nosocomial Infection Treatment Market Size by Type (2016-2021) 7.2.2 Europe Nosocomial Infection Treatment Market Size by Type (2022-2027) 7.2.3 Europe Nosocomial Infection Treatment Market Size by Type (2016-2027) 7.3 Europe Nosocomial Infection Treatment Market Size by Application 7.3.1 Europe Nosocomial Infection Treatment Market Size by Application (2016-2021) 7.3.2 Europe Nosocomial Infection Treatment Market Size by Application (2022-2027) 7.3.3 Europe Nosocomial Infection Treatment Market Size by Application (2016-2027) 7.4 Europe Nosocomial Infection Treatment Market Size by Country 7.4.1 Europe Nosocomial Infection Treatment Market Size by Country (2016-2021) 7.4.2 Europe Nosocomial Infection Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Nosocomial Infection Treatment Market Size (2016-2027) 8.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Type 8.2.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Application 8.3.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Nosocomial Infection Treatment Market Size by Region 8.4.1 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Nosocomial Infection Treatment Market Size (2016-2027) 9.2 Latin America Nosocomial Infection Treatment Market Size by Type 9.2.1 Latin America Nosocomial Infection Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Nosocomial Infection Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Nosocomial Infection Treatment Market Size by Type (2016-2027) 9.3 Latin America Nosocomial Infection Treatment Market Size by Application 9.3.1 Latin America Nosocomial Infection Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Nosocomial Infection Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Nosocomial Infection Treatment Market Size by Application (2016-2027) 9.4 Latin America Nosocomial Infection Treatment Market Size by Country 9.4.1 Latin America Nosocomial Infection Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Nosocomial Infection Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nosocomial Infection Treatment Market Size (2016-2027) 10.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Type 10.2.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Application 10.3.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Nosocomial Infection Treatment Market Size by Country 10.4.1 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott Nosocomial Infection Treatment Introduction 11.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.1.5 Abbott Recent Development 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Nosocomial Infection Treatment Introduction 11.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.2.5 Bayer Recent Development 11.3 Becton, Dickinson and Company 11.3.1 Becton, Dickinson and Company Company Details 11.3.2 Becton, Dickinson and Company Business Overview 11.3.3 Becton, Dickinson and Company Nosocomial Infection Treatment Introduction 11.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.3.5 Becton, Dickinson and Company Recent Development 11.4 Belimed 11.4.1 Belimed Company Details 11.4.2 Belimed Business Overview 11.4.3 Belimed Nosocomial Infection Treatment Introduction 11.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.4.5 Belimed Recent Development 11.5 BioMerieux 11.5.1 BioMerieux Company Details 11.5.2 BioMerieux Business Overview 11.5.3 BioMerieux Nosocomial Infection Treatment Introduction 11.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.5.5 BioMerieux Recent Development 11.6 Cantel 11.6.1 Cantel Company Details 11.6.2 Cantel Business Overview 11.6.3 Cantel Nosocomial Infection Treatment Introduction 11.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.6.5 Cantel Recent Development 11.7 Cepheid 11.7.1 Cepheid Company Details 11.7.2 Cepheid Business Overview 11.7.3 Cepheid Nosocomial Infection Treatment Introduction 11.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.7.5 Cepheid Recent Development 11.8 Getinge Group 11.8.1 Getinge Group Company Details 11.8.2 Getinge Group Business Overview 11.8.3 Getinge Group Nosocomial Infection Treatment Introduction 11.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.8.5 Getinge Group Recent Development 11.9 Kimberly-Clark Corp. 11.9.1 Kimberly-Clark Corp. Company Details 11.9.2 Kimberly-Clark Corp. Business Overview 11.9.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Introduction 11.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.9.5 Kimberly-Clark Corp. Recent Development 11.10 Merck & Co 11.10.1 Merck & Co Company Details 11.10.2 Merck & Co Business Overview 11.10.3 Merck & Co Nosocomial Infection Treatment Introduction 11.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.10.5 Merck & Co Recent Development 11.11 Nordion 11.11.1 Nordion Company Details 11.11.2 Nordion Business Overview 11.11.3 Nordion Nosocomial Infection Treatment Introduction 11.11.4 Nordion Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.11.5 Nordion Recent Development 11.12 Pfizer 11.12.1 Pfizer Company Details 11.12.2 Pfizer Business Overview 11.12.3 Pfizer Nosocomial Infection Treatment Introduction 11.12.4 Pfizer Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.12.5 Pfizer Recent Development 11.13 Roche 11.13.1 Roche Company Details 11.13.2 Roche Business Overview 11.13.3 Roche Nosocomial Infection Treatment Introduction 11.13.4 Roche Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.13.5 Roche Recent Development 11.14 Sakura Seiki 11.14.1 Sakura Seiki Company Details 11.14.2 Sakura Seiki Business Overview 11.14.3 Sakura Seiki Nosocomial Infection Treatment Introduction 11.14.4 Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.14.5 Sakura Seiki Recent Development 11.15 BioMérieux 11.15.1 BioMérieux Company Details 11.15.2 BioMérieux Business Overview 11.15.3 BioMérieux Nosocomial Infection Treatment Introduction 11.15.4 BioMérieux Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.15.5 BioMérieux Recent Development 11.16 Steris 11.16.1 Steris Company Details 11.16.2 Steris Business Overview 11.16.3 Steris Nosocomial Infection Treatment Introduction 11.16.4 Steris Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.16.5 Steris Recent Development 11.17 Johnson & Johnson 11.17.1 Johnson & Johnson Company Details 11.17.2 Johnson & Johnson Business Overview 11.17.3 Johnson & Johnson Nosocomial Infection Treatment Introduction 11.17.4 Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.17.5 Johnson & Johnson Recent Development 11.18 Sterigenics International, Inc. 11.18.1 Sterigenics International, Inc. Company Details 11.18.2 Sterigenics International, Inc. Business Overview 11.18.3 Sterigenics International, Inc. Nosocomial Infection Treatment Introduction 11.18.4 Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.18.5 Sterigenics International, Inc. Recent Development 11.18 Halyard Health, Inc. .1 Halyard Health, Inc. Company Details .2 Halyard Health, Inc. Business Overview .3 Halyard Health, Inc. Nosocomial Infection Treatment Introduction .4 Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) .5 Halyard Health, Inc. Recent Development 11.20 Advanced Sterilization Products 11.20.1 Advanced Sterilization Products Company Details 11.20.2 Advanced Sterilization Products Business Overview 11.20.3 Advanced Sterilization Products Nosocomial Infection Treatment Introduction 11.20.4 Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.20.5 Advanced Sterilization Products Recent Development 11.21 Matachana Group 11.21.1 Matachana Group Company Details 11.21.2 Matachana Group Business Overview 11.21.3 Matachana Group Nosocomial Infection Treatment Introduction 11.21.4 Matachana Group Revenue in Nosocomial Infection Treatment Business (2016-2021) 11.21.5 Matachana Group Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Nosocomial Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antibacterial Treatment Table 3. Key Players of Antiviral Treatment Table 4. Key Players of Antifungal Treatment Table 5. Global Nosocomial Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Nosocomial Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Nosocomial Infection Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Nosocomial Infection Treatment Market Share by Regions (2016-2021) Table 9. Global Nosocomial Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Nosocomial Infection Treatment Market Share by Regions (2022-2027) Table 11. Nosocomial Infection Treatment Market Trends Table 12. Nosocomial Infection Treatment Market Drivers Table 13. Nosocomial Infection Treatment Market Challenges Table 14. Nosocomial Infection Treatment Market Restraints Table 15. Global Nosocomial Infection Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Nosocomial Infection Treatment Market Share by Players (2016-2021) Table 17. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nosocomial Infection Treatment as of 2020) Table 18. Ranking of Global Top Nosocomial Infection Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Nosocomial Infection Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Nosocomial Infection Treatment Product Solution and Service Table 22. Date of Enter into Nosocomial Infection Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Nosocomial Infection Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Nosocomial Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Nosocomial Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Nosocomial Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Nosocomial Infection Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Nosocomial Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Nosocomial Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Nosocomial Infection Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Nosocomial Infection Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbott Company Details Table 63. Abbott Business Overview Table 64. Abbott Nosocomial Infection Treatment Product Table 65. Abbott Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 66. Abbott Recent Development Table 67. Bayer Company Details Table 68. Bayer Business Overview Table 69. Bayer Nosocomial Infection Treatment Product Table 70. Bayer Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 71. Bayer Recent Development Table 72. Becton, Dickinson and Company Company Details Table 73. Becton, Dickinson and Company Business Overview Table 74. Becton, Dickinson and Company Nosocomial Infection Treatment Product Table 75. Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 76. Becton, Dickinson and Company Recent Development Table 77. Belimed Company Details Table 78. Belimed Business Overview Table 79. Belimed Nosocomial Infection Treatment Product Table 80. Belimed Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 81. Belimed Recent Development Table 82. BioMerieux Company Details Table 83. BioMerieux Business Overview Table 84. BioMerieux Nosocomial Infection Treatment Product Table 85. BioMerieux Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 86. BioMerieux Recent Development Table 87. Cantel Company Details Table 88. Cantel Business Overview Table 89. Cantel Nosocomial Infection Treatment Product Table 90. Cantel Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 91. Cantel Recent Development Table 92. Cepheid Company Details Table 93. Cepheid Business Overview Table 94. Cepheid Nosocomial Infection Treatment Product Table 95. Cepheid Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 96. Cepheid Recent Development Table 97. Getinge Group Company Details Table 98. Getinge Group Business Overview Table 99. Getinge Group Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 100. Getinge Group Recent Development Table 101. Kimberly-Clark Corp. Company Details Table 102. Kimberly-Clark Corp. Business Overview Table 103. Kimberly-Clark Corp. Nosocomial Infection Treatment Product Table 104. Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 105. Kimberly-Clark Corp. Recent Development Table 106. Merck & Co Company Details Table 107. Merck & Co Business Overview Table 108. Merck & Co Nosocomial Infection Treatment Product Table 109. Merck & Co Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 110. Merck & Co Recent Development Table 111. Nordion Company Details Table 112. Nordion Business Overview Table 113. Nordion Nosocomial Infection Treatment Product Table 114. Nordion Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 115. Nordion Recent Development Table 116. Pfizer Company Details Table 117. Pfizer Business Overview Table 118. Pfizer Nosocomial Infection Treatment Product Table 119. Pfizer Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 120. Pfizer Recent Development Table 121. Roche Company Details Table 122. Roche Business Overview Table 123. Roche Nosocomial Infection Treatment Product Table 124. Roche Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 125. Roche Recent Development Table 126. Sakura Seiki Company Details Table 127. Sakura Seiki Business Overview Table 128. Sakura Seiki Nosocomial Infection Treatment Product Table 129. Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 130. Sakura Seiki Recent Development Table 131. BioMérieux Company Details Table 132. BioMérieux Business Overview Table 133. BioMérieux Nosocomial Infection Treatment Product Table 134. BioMérieux Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 135. BioMérieux Recent Development Table 136. Steris Company Details Table 137. Steris Business Overview Table 138. Steris Nosocomial Infection Treatment Product Table 139. Steris Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 140. Steris Recent Development Table 141. Johnson & Johnson Company Details Table 142. Johnson & Johnson Business Overview Table 143. Johnson & Johnson Nosocomial Infection Treatment Product Table 144. Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 145. Johnson & Johnson Recent Development Table 146. Sterigenics International, Inc. Company Details Table 147. Sterigenics International, Inc. Business Overview Table 148. Sterigenics International, Inc. Nosocomial Infection Treatment Product Table 149. Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 150. Sterigenics International, Inc. Recent Development Table 151. Halyard Health, Inc. Company Details Table 152. Halyard Health, Inc. Business Overview Table 153. Halyard Health, Inc. Nosocomial Infection Treatment Product Table 154. Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 155. Halyard Health, Inc. Recent Development Table 156. Advanced Sterilization Products Company Details Table 157. Advanced Sterilization Products Business Overview Table 158. Advanced Sterilization Products Nosocomial Infection Treatment Product Table 159. Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 160. Advanced Sterilization Products Recent Development Table 161. Matachana Group Company Details Table 162. Matachana Group Business Overview Table 163. Matachana Group Nosocomial Infection Treatment Product Table 164. Matachana Group Revenue in Nosocomial Infection Treatment Business (2016-2021) & (US$ Million) Table 165. Matachana Group Recent Development Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Global Nosocomial Infection Treatment Market Share by Type: 2020 VS 2027 Figure 2. Antibacterial Treatment Features Figure 3. Antiviral Treatment Features Figure 4. Antifungal Treatment Features Figure 5. Global Nosocomial Infection Treatment Market Share by Application: 2020 VS 2027 Figure 6. Ventilator Associated Pneumonia Case Studies Figure 7. Urinary Tract Infection Case Studies Figure 8. Blood Stream Infection Case Studies Figure 9. Surgical Site Infection Case Studies Figure 10. Gastrointestinal Infection Case Studies Figure 11. MRSA Case Studies Figure 12. Nosocomial Infection Treatment Report Years Considered Figure 13. Global Nosocomial Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Nosocomial Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Nosocomial Infection Treatment Market Share by Regions: 2020 VS 2027 Figure 16. Global Nosocomial Infection Treatment Market Share by Regions (2022-2027) Figure 17. Global Nosocomial Infection Treatment Market Share by Players in 2020 Figure 18. Global Top Nosocomial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nosocomial Infection Treatment as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Nosocomial Infection Treatment Revenue in 2020 Figure 20. Global Nosocomial Infection Treatment Revenue Market Share by Type (2016-2021) Figure 21. Global Nosocomial Infection Treatment Revenue Market Share by Type (2022-2027) Figure 22. North America Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Nosocomial Infection Treatment Market Share by Type (2016-2027) Figure 24. North America Nosocomial Infection Treatment Market Share by Application (2016-2027) Figure 25. North America Nosocomial Infection Treatment Market Share by Country (2016-2027) Figure 26. United States Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Nosocomial Infection Treatment Market Share by Type (2016-2027) Figure 30. Europe Nosocomial Infection Treatment Market Share by Application (2016-2027) Figure 31. Europe Nosocomial Infection Treatment Market Share by Country (2016-2027) Figure 32. Germany Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Nosocomial Infection Treatment Market Share by Type (2016-2027) Figure 40. Asia-Pacific Nosocomial Infection Treatment Market Share by Application (2016-2027) Figure 41. Asia-Pacific Nosocomial Infection Treatment Market Share by Region (2016-2027) Figure 42. China Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Nosocomial Infection Treatment Market Share by Type (2016-2027) Figure 50. Latin America Nosocomial Infection Treatment Market Share by Application (2016-2027) Figure 51. Latin America Nosocomial Infection Treatment Market Share by Country (2016-2027) Figure 52. Mexico Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Nosocomial Infection Treatment Market Share by Type (2016-2027) Figure 56. Middle East & Africa Nosocomial Infection Treatment Market Share by Application (2016-2027) Figure 57. Middle East & Africa Nosocomial Infection Treatment Market Share by Country (2016-2027) Figure 58. Turkey Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Nosocomial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Abbott Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 62. Bayer Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 63. Becton, Dickinson and Company Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 64. Belimed Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 65. BioMerieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 66. Cantel Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 67. Cepheid Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 68. Getinge Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 69. Kimberly-Clark Corp. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 70. Merck & Co Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 71. Nordion Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 72. Pfizer Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 73. Roche Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 74. Sakura Seiki Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 75. BioMérieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 76. Steris Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 77. Johnson & Johnson Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 78. Sterigenics International, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 79. Halyard Health, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 80. Advanced Sterilization Products Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 81. Matachana Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2016-2021) Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

Abbott Bayer Becton, Dickinson and Company Belimed BioMerieux Cantel Cepheid Getinge Group Kimberly-Clark Corp. Merck & Co Nordion Pfizer Roche Sakura Seiki BioMérieux Steris Johnson & Johnson Sterigenics International, Inc. Halyard Health, Inc. Advanced Sterilization Products Matachana Group